BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23604979)

  • 21. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.
    Siewert E; Bort R; Kluge R; Heinrich PC; Castell J; Jover R
    Hepatology; 2000 Jul; 32(1):49-55. PubMed ID: 10869288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11/3A4 dysfunction through the pregnane X receptor.
    Sun HY; Yan YJ; Li YH; Lv L
    J Ethnopharmacol; 2019 Jan; 229():246-255. PubMed ID: 30342195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.
    Gavito AL; Cabello R; Suarez J; Serrano A; Pavón FJ; Vida M; Romero M; Pardo V; Bautista D; Arrabal S; Decara J; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
    Br J Pharmacol; 2016 Mar; 173(6):1070-84. PubMed ID: 26750868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
    Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of intestinal flora on the expression of cytochrome P450 3A in the liver].
    Ishii M; Toda T; Ikarashi N; Ochiai W; Sugiyama K
    Yakugaku Zasshi; 2012; 132(3):301-10. PubMed ID: 22382834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury.
    Langdale LA; Hoagland V; Benz W; Riehle KJ; Campbell JS; Liggitt DH; Fausto N
    J Hepatol; 2008 Aug; 49(2):198-206. PubMed ID: 18471922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of SPG/indomethacin treatment on sepsis, interleukin-6 production, and expression of hepatic cytochrome P450 isoforms in differing strains of mice.
    Saito M; Nameda S; Miura NN; Adachi Y; Ohno N
    J Immunotoxicol; 2009 Mar; 6(1):42-8. PubMed ID: 19519162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.
    Su J; Chang C; Xiang Q; Zhou ZW; Luo R; Yang L; He ZX; Yang H; Li J; Bei Y; Xu J; Zhang M; Zhang Q; Su Z; Huang Y; Pang J; Zhou SF
    Drug Des Devel Ther; 2014; 8():2555-602. PubMed ID: 25548518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How important is intestinal cytochrome P450 3A metabolism?
    van Herwaarden AE; van Waterschoot RA; Schinkel AH
    Trends Pharmacol Sci; 2009 May; 30(5):223-7. PubMed ID: 19328560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.
    Leu JI; Crissey MA; Leu JP; Ciliberto G; Taub R
    Mol Cell Biol; 2001 Jan; 21(2):414-24. PubMed ID: 11134330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 regulates hepatic transporters during acute-phase response.
    Siewert E; Dietrich CG; Lammert F; Heinrich PC; Matern S; Gartung C; Geier A
    Biochem Biophys Res Commun; 2004 Sep; 322(1):232-8. PubMed ID: 15313196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
    Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
    Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components.
    Lee C; Riddick DS
    Can J Physiol Pharmacol; 2012 Oct; 90(10):1354-63. PubMed ID: 22978700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved.
    Jover R; Bort R; Gómez-Lechón MJ; Castell JV
    FASEB J; 2002 Nov; 16(13):1799-801. PubMed ID: 12354697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.
    Moreau A; Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):871-878. PubMed ID: 28260174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of NF-κB in the reversal of CYP3A down-regulation induced by sea buckthorn in BCG-induced rats.
    Liu F; Wang T; Li X; Jia J; Lin Q; Xue Y
    PLoS One; 2020; 15(9):e0238810. PubMed ID: 32915856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.
    Kinloch RD; Lee CM; van Rooijen N; Morgan ET
    Biochem Pharmacol; 2011 Aug; 82(3):312-21. PubMed ID: 21570957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis.
    Lu H; Lei X; Zhang Q
    BMC Gastroenterol; 2015 Jul; 15():94. PubMed ID: 26219821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism.
    Monshouwer M; Witkamp RF; Nijmeijer SM; Van Leengoed LA; Vernooy HC; Verheijden JH; Van Miert AS
    J Vet Pharmacol Ther; 1996 Oct; 19(5):382-88. PubMed ID: 8905573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.